Tržní kapitalizace společnosti 4SC AG
Jaká je hodnota metriky Tržní kapitalizace společnosti 4SC AG?
Hodnota metriky Tržní kapitalizace společnosti 4SC AG je $73.02M
Jaká je definice metriky Tržní kapitalizace?
Tržní kapitalizace (Market cap) je tržní hodnotou vydaných akcií obchodované společnosti a rovná se ceně akcií v daném čase vynásobené počtem kusů vydaných akcií .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Tržní kapitalizace společností v sektoru Health Care sektor na XETRA ve srovnání se společností 4SC AG
Čemu se věnuje společnost 4SC AG?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Firmy s metrikou tržní kapitalizace podobnou společnosti 4SC AG
- Hodnota metriky Tržní kapitalizace společnosti Pimco New York Municipal Income Fund je $72.86M
- Hodnota metriky Tržní kapitalizace společnosti Coventry Ltd je $72.93M
- Hodnota metriky Tržní kapitalizace společnosti Australian Pacific Coal je $72.94M
- Hodnota metriky Tržní kapitalizace společnosti Msl Soltns Fpo je $72.97M
- Hodnota metriky Tržní kapitalizace společnosti GAN je $72.99M
- Hodnota metriky Tržní kapitalizace společnosti Eleco Plc je $73.00M
- Hodnota metriky Tržní kapitalizace společnosti 4SC AG je $73.02M
- Hodnota metriky Tržní kapitalizace společnosti Quicklogic Corp je $73.04M
- Hodnota metriky Tržní kapitalizace společnosti Sbf Ag je $73.06M
- Hodnota metriky Tržní kapitalizace společnosti King's Flair International () je $73.12M
- Hodnota metriky Tržní kapitalizace společnosti Maxicity je $73.19M
- Hodnota metriky Tržní kapitalizace společnosti Permanent Magnets je $73.21M
- Hodnota metriky Tržní kapitalizace společnosti HCL Infosystems je $73.21M